Vor Bio Appoints Navid Khan as Chief Medical Affairs Officer.

Vor Bio has appointed Navid Z. Khan, Ph.D., as Chief Medical Affairs Officer. Khan has over two decades of experience in medical affairs, commercial, and R&D functions, overseeing 40 development programs and guiding seven product launches in neurology, immunology, and infectious diseases. He joins Vor Bio from argenx, where he led medical strategy and execution for four launches of VYVGART and VYVGART Hytrulo.

Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company focused on transforming the treatment of autoimmune diseases, has appointed Dr. Navid Z. Khan, Ph.D., as its Chief Medical Affairs Officer Vor Bio Names Navid Khan as Chief Medical Affairs Officer^[1]. Dr. Khan brings over two decades of experience in medical affairs, commercial operations, and R&D, with a proven track record of leading successful product launches in rare neurology and immunology indications.

Dr. Khan joins Vor Bio from argenx, where he served as Head of Neuromuscular Therapeutic Area, Medical Affairs, leading the integrated medical strategy and execution for four launches of VYVGART and VYVGART Hytrulo Vor Bio Names Navid Khan as Chief Medical Affairs Officer^[1]. Prior to argenx, he held senior leadership positions at Akouos Inc. and Sarepta Therapeutics, where he played a pivotal role in the launch of three Duchenne muscular dystrophy therapies and prepared Sarepta’s Medical Affairs organization for gene therapy programs Vor Bio Names Navid Khan as Chief Medical Affairs Officer^[1].

“Navid is an exceptional leader with a proven track record of building world-class medical affairs organizations and executing multiple high-impact product launches,” said Jean-Paul Kress, M.D., Chief Executive Officer and Chairman of the Board of Vor Bio. “His deep scientific expertise, combined with his ability to connect with patients, physicians, and global stakeholders, will be invaluable as we advance telitacicept and shape our broader autoimmune portfolio” Vor Bio Names Navid Khan as Chief Medical Affairs Officer^[1].

Dr. Khan earned his Ph.D. in Biomedical Engineering and Biotechnology from the University of Massachusetts, Lowell, and his B.S. in Biochemistry and Molecular Biology from the University of Massachusetts, Amherst Vor Bio Names Navid Khan as Chief Medical Affairs Officer^[1]. He is excited about the opportunity to join Vor Bio at this critical juncture in its development and looks forward to contributing to the company’s mission of transforming the treatment of autoimmune diseases.